Cadmus Rich

Insider Reports History

Entity
Individual
Location
C/O Aura Biosciences, Inc., 85 Bolton Street, Cambridge, MA
Signature
/s/ Julie Feder, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cadmus Rich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aura Biosciences, Inc. Chief Medical Officer, Head of R&D Common Stock 58.7K $449K $7.64 Jan 19, 2023 Direct
Aura Biosciences, Inc. Chief Medical Officer, Head of R&D Stock Option (Right to Buy) 52.5K Jan 19, 2023 Direct

Insider Reports Filed by Cadmus Rich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AURA Aura Biosciences, Inc. Jan 19, 2023 2 $0 4 Jan 23, 2023 Chief Medical Officer, Head of R&D
AURA Aura Biosciences, Inc. Oct 31, 2022 1 -$20.8K 4 Nov 2, 2022 Chief Medical Officer, Head of R&D
AURA Aura Biosciences, Inc. Oct 28, 2021 2 $0 4 Oct 29, 2021 Chief Medical Officer Head of R&D
AURA Aura Biosciences, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 Chief Medical Officer Head of R&D